Epigenomics (ECX) AI Stock Analysis

Epigenomics

(Frankfurt:ECX)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

Epigenomics (ECX) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 953.71K
Dividend Yield: ―
Average Volume (3M): 336
Price to Earnings (P/E): -2.4
Beta (1Y): 1.40
Revenue Growth: 825.00%
EPS Growth: 91.38%
Country: Germany
Employees: 3
Sector: General
Sector Strength: 55
Industry: Medical - Diagnostics & Research

Epigenomics Business Overview & Revenue Model

Company Description

Epigenomics AG currently has no significant business activities. Historically, the firm concentrated its efforts on developing liquid biopsy methods for the early identification of cancer. The company was established in 1998 and is based in Heidelber...

Epigenomics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

DE:ECX against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:M3V	66Neutral	EUR 37.13M	26.84	7.77%	4.66%	-6.92%	-67.82%
DE:SIS	60Neutral	EUR 563.45M	39.78	18.80%	0.86%	-18.11%	―
DE:SBS	57Neutral	EUR 273.51M	-562.50	-0.17%	2.67%	―	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
DE:V3V	46Neutral	EUR 48.46M	-6.41	-94.93%	―	0.06%	22.85%
DE:BNN	44Neutral	EUR 61.61M	-4.27	590.52%	―	―	―

* General Sector Average

Performance Comparison

DE:ECX and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:ECX	Epigenomics AG	0.87	0.01	0.81%
DE:BNN	B.R.A.I.N. Biotechnology Research and Information Network	2.82	0.49	21.03%
DE:SIS	First Sensor	54.50	-1.82	-3.23%
DE:M3V	MeVis Medical Solutions	20.40	-3.31	-13.95%
DE:SBS	STRATEC Biomedical	22.50	0.32	1.43%
DE:V3V	VITA 34	2.78	-2.52	-47.55%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Epigenomics AI Stock Analysis